134 related articles for article (PubMed ID: 9394848)
1. Relaxation of insulin-like growth factor-II gene imprinting in human gynecologic tumors.
Yaginuma Y; Nishiwaki K; Kitamura S; Hayashi H; Sengoku K; Ishikawa M
Oncology; 1997; 54(6):502-7. PubMed ID: 9394848
[TBL] [Abstract][Full Text] [Related]
2. Genomic imprinting of IGF-II and H19 in adult human pancreatic tissues.
Micha AE; Hähnel S; Friess H; Büchler MW; Adler G; Gress TM
Digestion; 1999; 60(5):477-83. PubMed ID: 10473973
[TBL] [Abstract][Full Text] [Related]
3. Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia.
Vorwerk P; Wex H; Bessert C; Hohmann B; Schmidt U; Mittler U
Leuk Res; 2003 Sep; 27(9):807-12. PubMed ID: 12804639
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor II in uterine smooth-muscle tumors: maintenance of genomic imprinting in leiomyomata and loss of imprinting in leiomyosarcomata.
Vu TH; Yballe C; Boonyanit S; Hoffman AR
J Clin Endocrinol Metab; 1995 May; 80(5):1670-6. PubMed ID: 7745016
[TBL] [Abstract][Full Text] [Related]
5. Loss of IGF-II imprinting in endometrial tumors: overexpression in carcinosarcoma.
Roy RN; Gerulath AH; Cecutti A; Bhavnani BR
Cancer Lett; 2000 May; 153(1-2):67-73. PubMed ID: 10779632
[TBL] [Abstract][Full Text] [Related]
6. IGF-II in primary human colorectal tumors: peptide level, activated promoters, parental imprinting and gene rearrangement.
Winkler R; Delacroix L; Bensbaho K; Lambert S; Collette J; Hodzic D
Horm Metab Res; 1999; 31(2-3):148-54. PubMed ID: 10226796
[TBL] [Abstract][Full Text] [Related]
7. Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer.
Chen CL; Ip SM; Cheng D; Wong LC; Ngan HY
Clin Cancer Res; 2000 Feb; 6(2):474-9. PubMed ID: 10690526
[TBL] [Abstract][Full Text] [Related]
8. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues.
Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB
Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946
[TBL] [Abstract][Full Text] [Related]
9. Frequent loss of imprinting of the H19 and IGF-II genes in ovarian tumors.
Kim HT; Choi BH; Niikawa N; Lee TS; Chang SI
Am J Med Genet; 1998 Dec; 80(4):391-5. PubMed ID: 9856569
[TBL] [Abstract][Full Text] [Related]
10. Recurrence of urothelial carcinoma of the bladder: a role for insulin-like growth factor-II loss of imprinting and cytoplasmic E-cadherin immunolocalization.
Gallagher EM; O'Shea DM; Fitzpatrick P; Harrison M; Gilmartin B; Watson JA; Clarke T; Leonard MO; McGoldrick A; Meehan M; Watson C; Furlong F; O'Kelly P; Fitzpatrick JM; Dervan PA; O'Grady A; Kay EW; McCann A
Clin Cancer Res; 2008 Nov; 14(21):6829-38. PubMed ID: 18980977
[TBL] [Abstract][Full Text] [Related]
11. Expression and parental imprinting of the H19 gene in human rhabdomyosarcoma.
Casola S; Pedone PV; Cavazzana AO; Basso G; Luksch R; d'Amore ES; Carli M; Bruni CB; Riccio A
Oncogene; 1997 Mar; 14(12):1503-10. PubMed ID: 9136994
[TBL] [Abstract][Full Text] [Related]
12. [Genomic imprinting of insulin-like growth factor II in prostate cancer and its clinical significance].
Liu ZW; Zhou FJ; Luo YM; Qin ZK; Wang DJ; Luo JH; Han H; Li YH; Wang H
Ai Zheng; 2006 Jun; 25(6):765-70. PubMed ID: 16764778
[TBL] [Abstract][Full Text] [Related]
13. Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors.
Pedone PV; Tirabosco R; Cavazzana AO; Ungaro P; Basso G; Luksch R; Carli M; Bruni CB; Frunzio R; Riccio A
Hum Mol Genet; 1994 Jul; 3(7):1117-21. PubMed ID: 7981680
[TBL] [Abstract][Full Text] [Related]
14. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
[TBL] [Abstract][Full Text] [Related]
15. Imprinting and expression of insulin-like growth factor-II and H19 in normal breast tissue and breast tumor.
Yballe CM; Vu TH; Hoffman AR
J Clin Endocrinol Metab; 1996 Apr; 81(4):1607-12. PubMed ID: 8636375
[TBL] [Abstract][Full Text] [Related]
16. IGF2 but not H19 shows loss of imprinting in human glioma.
Uyeno S; Aoki Y; Nata M; Sagisaka K; Kayama T; Yoshimoto T; Ono T
Cancer Res; 1996 Dec; 56(23):5356-9. PubMed ID: 8968084
[TBL] [Abstract][Full Text] [Related]
17. High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.
Douc-Rasy S; Barrois M; Fogel S; Ahomadegbe JC; Stéhelin D; Coll J; Riou G
Oncogene; 1996 Jan; 12(2):423-30. PubMed ID: 8570220
[TBL] [Abstract][Full Text] [Related]
18. Loss of imprinting in hepatoblastoma.
Rainier S; Dobry CJ; Feinberg AP
Cancer Res; 1995 May; 55(9):1836-8. PubMed ID: 7728748
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma.
Davies SM
Cancer Res; 1993 Oct; 53(20):4781-3. PubMed ID: 8402661
[TBL] [Abstract][Full Text] [Related]
20. Multipoint imprinting analysis indicates a common precursor cell for gonadal and nongonadal pediatric germ cell tumors.
Schneider DT; Schuster AE; Fritsch MK; Hu J; Olson T; Lauer S; Göbel U; Perlman EJ
Cancer Res; 2001 Oct; 61(19):7268-76. PubMed ID: 11585765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
